We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

10 hedge funds and large institutions have $7.55M invested in Yield10 Bioscience, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

15% more capital invested

Capital invested by funds: $6.59M → $7.55M (+$962K)

11% more funds holding

Funds holding: 9 → 10 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $5K

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
$5K
Net Calls
-$5K
Net Calls Change
-$28K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$29.6K
2
Citadel Advisors
Citadel Advisors
Florida
+$14.8K
3
FA
FCG Advisors
New Jersey
+$14.8K

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$311K
2
GC
GMT Capital
Georgia
-$183K
3
IA
IFP Advisors
Florida
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Birchview Capital
Vermont
$3.87M – – –
CC
2
Cannell & Co
New York
$1.46M – – –
OIM
3
Oracle Investment Management
Connecticut
$1.38M -$311K -21 -22%
BIT
4
BlackRock Institutional Trust
California
$296K – – –
FA
5
FCG Advisors
New Jersey
$228K +$14.8K +1 +9%
Vanguard Group
6
Vanguard Group
Pennsylvania
$201K – – –
UBS Group
7
UBS Group
Switzerland
$33K +$29.6K +2 New
MCM
8
McRae Capital Management
New Jersey
$24K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$20K +$14.8K +1 New
Morgan Stanley
10
Morgan Stanley
New York
$7K – – –
Group One Trading
11
Group One Trading
Illinois
$5K – – –
BA
12
BlackRock Advisors
Delaware
$4K – – –
CG
13
Cutler Group
California
$4K – – –
BFA
14
BlackRock Fund Advisors
California
$3K – – –
BIM
15
BlackRock Investment Management
Delaware
$3K – – –
Manulife (Manufacturers Life Insurance)
16
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K – – –
TWA
17
TCI Wealth Advisors
Arizona
$3K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$3K – – –
MFS
19
MSI Financial Services
Massachusetts
$1K – – –
PSC
20
Prentiss Smith & Co
Vermont
$1K – – –
Geode Capital Management
21
Geode Capital Management
Massachusetts
$68 – – –
WEC
22
Winslow Evans & Crocker
Massachusetts
$63 – – –
GC
23
GMT Capital
Georgia
– -$183K -12 Closed
IA
24
IFP Advisors
Florida
– -$1K – –

YTEN Hedge Fund Activity: Q1 2016 in Review

10 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2016, worth a combined $7.55M — up 15% from $6.59M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new YTEN positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $29.6K. The largest seller was Oracle Investment Management, cutting an estimated $311K.

  • 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2016, up from 9 in Q4 2015.
  • Funds reported $7.55M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2016, up 15% quarter-over-quarter.
  • 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2016 and 1 closed out, a net change of +1 holder.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2016 was UBS Group, an estimated $29.6K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2016 was Oracle Investment Management, an estimated $311K sold.

Based on aggregated 13F filings for Q1 2016.